Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Some Companies Say 'No' To China's Latest VBP Round
Branded Growth Without Price Cuts Still Possible
Aug 25 2020
•
By
Brian Yang
MNCs MOSTLY SAY 'NO' TO LOWERING PRICES IN CHINA'S LATEST VPB ROUND • Source: Shutterstock
Keep up with the top pharma business news of the week. On the go.
Scrip brings you a weekly bulletin of top picks.
More from China
More from Focus On Asia